Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| AbbVie Inc. | 74,430 | reported | 27 Feb 2026 | tx 29+280,566−81,421.17 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 Feb 2026 | TAX_WITHHOLDING | AbbVie Inc. | 12,874 | 232.08 USD | |
| 18 Feb 2026 | GRANT_AWARD | AbbVie Inc. | 13,031 | 0.00 USD | |
| 18 Feb 2026 | GRANT_AWARD | AbbVie Inc. | 6,222 | 0.00 USD | |
| 18 Feb 2026 | GRANT_AWARD | AbbVie Inc. | 4,632 | 0.00 USD | |
| 18 Feb 2026 | GRANT_AWARD | AbbVie Inc. | 5,172 | 0.00 USD | |
| 18 Feb 2026 | GRANT_AWARD | AbbVie Inc. | 20,312 | 0.00 USD | deriv |
| 05 Aug 2025 | SALE | AbbVie Inc. | 10,061 | 198.59 USD | |
| 05 Aug 2025 | SALE | AbbVie Inc. | 3,234.17 | 198.27 USD | |
| 28 Feb 2025 | TAX_WITHHOLDING | AbbVie Inc. | 11,230 | 205.02 USD | |
| 13 Feb 2025 | GRANT_AWARD | AbbVie Inc. | 11,017 | 0.00 USD | |
| 13 Feb 2025 | GRANT_AWARD | AbbVie Inc. | 5,174 | 0.00 USD | |
| 13 Feb 2025 | GRANT_AWARD | AbbVie Inc. | 4,634 | 0.00 USD | |
| 13 Feb 2025 | GRANT_AWARD | AbbVie Inc. | 4,520 | 0.00 USD | |
| 13 Feb 2025 | GRANT_AWARD | AbbVie Inc. | 23,437 | 0.00 USD | deriv |
| 20 Mar 2024 | SALE | AbbVie Inc. | 21,082 | 176.30 USD | |
| 28 Feb 2024 | TAX_WITHHOLDING | AbbVie Inc. | 16,771 | 178.99 USD | |
| 15 Feb 2024 | GRANT_AWARD | AbbVie Inc. | 4,634 | 0.00 USD | |
| 15 Feb 2024 | GRANT_AWARD | AbbVie Inc. | 4,520 | 0.00 USD | |
| 15 Feb 2024 | GRANT_AWARD | AbbVie Inc. | 6,042 | 0.00 USD | |
| 15 Feb 2024 | GRANT_AWARD | AbbVie Inc. | 22,657 | 0.00 USD | |
| 15 Feb 2024 | GRANT_AWARD | AbbVie Inc. | 21,433 | 0.00 USD | deriv |
| 26 Dec 2023 | SALE | AbbVie Inc. | 2,912 | 154.72 USD | |
| 28 Feb 2020 | TAX_WITHHOLDING | AbbVie Inc. | 2,355 | 85.42 USD | |
| 20 Feb 2020 | GRANT_AWARD | AbbVie Inc. | 5,316 | 0.00 USD | |
| 20 Feb 2020 | GRANT_AWARD | AbbVie Inc. | 72,013 | 0.00 USD | deriv |